A review of the use of antioxidant supplements in the treatment of human oral leukoplakia
β Scribed by Dr. George E. Kaugars; Sol Silverman Jr.; John G. L. Lovas; Richard B. Brandt; Joan S. Thompson; Vishwa N. Singh
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 599 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
β¦ Synopsis
Over the past twenty years, research into the role of antioxidants in the prevention of cancer has increased dramatically. The use of antioxidant supplements to treat oral leukoplakia has gained acceptance due to the success demonstrated in several clinical trials. This review discusses the role of antioxidants in the development of cancer and their possible use in the treatment of oral leukoplakia.
π SIMILAR VOLUMES
Laryngeal keratosis (LK) is a precancerous mucosal change with great similarity to oral leukoplakia. Its malignant transformation rate varies from 1% to 40%, with the highest rates being found in patients microscopically diagnosed as "keratosis with atypia" (KWA). Recent evidence indicates that even
## Abstract This study assesses the effects of oral BCG, as a single agent, on tumor progression and on cellβmediated immune function in patients with metastatic malignant melanoma. Thirty patients were studied including 22 with measurable metastatic lesions and 8 with no detectable disease, follow